Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study

BACKGROUND AND PURPOSE: Nicergoline is an ergoline derivative that is used to treat cognitive deficits in cerebrovascular disease and various forms of dementia. Although therapeutic effects of nicergoline have been established, little is known about its effects on cerebral perfusion in Alzheimer...

Descripción completa

Detalles Bibliográficos
Autores principales: Im, Jooyeon J., Jeong, Hyeonseok S., Park, Jong-Sik, Yang, YoungSoon, Na, Seung-Hee, Oh, Jin Kyoung, Chung, Yong-An, Song, In-Uk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dementia Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428003/
https://www.ncbi.nlm.nih.gov/pubmed/30906380
http://dx.doi.org/10.12779/dnd.2017.16.4.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428003/
https://www.ncbi.nlm.nih.gov/pubmed/30906380
http://dx.doi.org/10.12779/dnd.2017.16.4.104

Ejemplares similares